Xenon Pharmaceuticals Inc. (XENE) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-02-10
11:23 am
Sale		2021-12-3113GXenon Pharmaceuticals Inc.
XENE		ADAGE CAPITAL PARTNERS GP L.L.C.665,000
1.290%		-1,785,000decrease
(-72.86%)		Filing
History
2022-02-09
10:04 am
Purchase		2022-02-0813GXenon Pharmaceuticals Inc.
XENE		FMR LLC3,910,017
7.579%		1,284,465increase
(+48.92%)		Filing
History
2021-10-28
5:24 pm
Purchase		2021-10-2713GXenon Pharmaceuticals Inc.
XENE		Point72 Asset Management, L.P.2,641,253
5.100%		2,641,253increase
(New Position)		Filing
History
2021-02-12
6:52 pm
Sale		2020-12-3113GXenon Pharmaceuticals Inc.
XENE		BIOTECHNOLOGY VALUE FUND L P3,499,346
10.000%		-17,505decrease
(-0.50%)		Filing
History
2021-02-12
5:13 pm
Purchase		2020-12-3113GXenon Pharmaceuticals Inc.
XENE		ORBIMED ADVISORS LLC1,711,305
4.890%		1,076,493increase
(+169.58%)		Filing
History
2021-02-12
08:14 am
Purchase		2020-12-3113GXenon Pharmaceuticals Inc.
XENE		Avoro Capital Advisors LLC2,800,000
8.000%		400,000increase
(+16.67%)		Filing
History
2021-02-11
07:59 am
Purchase		2020-12-3113GXenon Pharmaceuticals Inc.
XENE		ADAGE CAPITAL PARTNERS GP L.L.C.2,450,000
7.000%		525,000increase
(+27.27%)		Filing
History
2021-02-08
10:35 am
Purchase		2021-02-0513GXenon Pharmaceuticals Inc.
XENE		FMR LLC2,625,552
7.499%		2,625,552increase
(New Position)		Filing
History
Goto Prev, 0, 1